Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Technology
Rounak Jain

Tesla's Optimus Bot Gets New Hands As Neuralink's FDA-Approved BCI Trials Begin

Tesla Inc. (NASDAQ:TSLA) has introduced a major enhancement to its humanoid robot, Optimus, featuring new hands.

What Happened: This announcement aligns with Neuralink‘s recent FDA approval for its CONVOY Study. This trial will let Neuralink test its Brain-to-Computer (BCI) implant with assistive robotic arms – such as those of the Optimus bot.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.